The Safety and Feasibility of Same-Day Discharge After Implantation of MICRA Transcatheter Leadless Pacemaker System.

Autor: Kiani S; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Black GB; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Rao B; Emory University School of Medicine, Department of Medicine., Thakkar N; Emory University School of Medicine, Department of Medicine., Massad C; Emory University School of Medicine, Department of Medicine., Patel AV; Emory University., Lu MLR; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Merchant FM; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Hoskins MH; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., De Lurgio DB; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Patel AM; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Shah AD; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Leon AR; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Westerman SB; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., Lloyd MS; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease., El-Chami MF; Emory University School of Medicine, Department of Medicine, Division of Cardiovascular Disease.
Jazyk: angličtina
Zdroj: Journal of atrial fibrillation [J Atr Fibrillation] 2019 Jun 30; Vol. 12 (1), pp. 2153. Date of Electronic Publication: 2019 Jun 30 (Print Publication: 2019).
DOI: 10.4022/jafib.2153
Abstrakt: Background: Data suggests that same day discharge after implantation of trans-venous pacemakers is safe and feasible. We sought to determine whether same day discharge was feasible and safe following implantation of Medtronic MICRA leadless pacemakers.
Methods: We retrospectively identified all patients undergoing MICRA placement at our institution between April 2014 to August 2018 (n=167). Patients were stratified into two groups: those discharged on the same day as their procedure (SD, n=25), and those observed for at least one night in the hospital (HD, n=142). The primary endpoint included a composite of major complications including: access site complications, new pericardial effusion, device dislodgement, and need for device revision up to approximately 45 days of follow up.
Results: SD and HD had similar age (75±13 vs. 75±13 years, p=0.923), prevalence of male sex (49 vs. 44%, p=0.669), and frequency of high-grade heart block as an indication for pacing (38 vs. 32%, p=0.596). There were more Caucasians in the SD group (72 vs. 66%, p=0.038). The rate of the composite endpoint was statistically non-significantly higher in the HD group (3.5% vs. 0.0%, p=1.00). The rates of each individual components comprising the composite endpoint were similar between groups.
Conclusions: Our data suggest that in appropriately selected patients, same day discharge can occur safely following Micra leadless pacemaker implantation.
Databáze: MEDLINE